Merck & Co. MRK Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $14.69B+10.3% | $13.32B+92.8% | $6.91B-45.9% | $12.77B+56.4% | ||
| $0-100% | $447M+77.4% | $252M-49.4% | $498M— | ||
| $11.78B+14.6% | $10.28B-0.7% | $10.35B+9.5% | $9.45B+2.4% | ||
| $5.68B+35.5% | $4.19B+25.2% | $3.35B+14.0% | $2.94B+33.9% | ||
| $43.52B+12.2% | $38.78B+20.6% | $32.17B-9.9% | $35.72B+18.0% | ||
| $25.32B+6.5% | $23.78B+3.2% | $23.05B+7.6% | $21.42B+11.1% | ||
| $21.58B-0.4% | $21.67B+2.2% | $21.2B0.0% | $21.2B-0.3% | ||
| $956M+5.1% | $910M— | —— | —— | ||
| $136.87B+16.9% | $117.11B+9.8% | $106.68B-2.3% | $109.16B+3.3% | ||
| $4.4B+8.0% | $4.08B+4.0% | $3.92B-8.0% | $4.26B-7.5% | ||
| $28.33B-0.3% | $28.42B+10.6% | $25.69B+6.0% | $24.24B+1.5% | ||
| $49.3B+32.9% | $37.1B+5.7% | $35.1B+14.3% | $30.7B-7.3% | ||
| $324M-39.8% | $538M— | —— | —— | ||
| $73.08B+15.9% | $63.07B+17.0% | $53.9B-11.8% | $61.08B+13.8% | ||
| $52.61B+13.6% | $46.31B+23.2% | $37.58B-18.3% | $45.99B+20.4% | ||
| $136.87B+16.9% | $117.11B+9.8% | $106.68B-2.3% | $109.16B+3.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Merck & Co.'s total assets?
- Merck & Co. (MRK) holds $128.69B in total assets, up 11.8% year over year.
- How much debt does Merck & Co. have?
- Merck & Co. carries $49.1B in total debt against $45.9B of shareholders' equity, a debt-to-equity ratio of 1.07.
- How much cash does Merck & Co. have?
- Merck & Co. holds $5.4B in cash and equivalents.
- Can Merck & Co. cover its short-term obligations?
- Its current ratio is 1.30 — current assets exceed current liabilities.
- Where does Merck & Co.'s balance sheet data come from?
- Every line is extracted from Merck & Co.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
